18:2 Lyso PA
Manufacturer: Sigma Aldrich
CAS Number: 65528-85-0
Synonym(S): 1-(9Z,12Z-octadecadienoyl)-2-hydroxy-sn-glycero-3-phosphate (sodium salt); PA(18:2(9Z,12Z)/0:0)
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| 10 MG | 857138C-10-MG | In Stock | ₹ 67,090.05 |
| 25 MG | 857138C-25-MG | In Stock | ₹ 1,45,258.43 |
857138C - 10 MG
In Stock
Quantity
1
Base Price: ₹ 67,090.05
GST (18%): ₹ 12,076.209
Total Price: ₹ 79,166.259
description
1-linoleoyl-2-hydroxy-sn-glycero-3-phosphate (sodium salt), chloroform
Assay
>99% (LPA; may contain up to 10% of the 2-LPA isomer, TLC)
form
liquid
packaging
pkg of 1 × 1 mL (857138C-10mg)pkg of 1 × 2.5 mL (857138C-25mg)
manufacturer/tradename
Avanti Polar Lipids
concentration
10 mg/mL (857138C-10mg)10 mg/mL (857138C-25mg)
lipid type
cardiolipinsphospholipids
shipped in
dry ice
storage temp.
−20°C
Related Products
Description
- General description: Lysophosphatidic acid (LPA) is a lysophospholipid comprising of glycerol 3-phosphate (G3P), fatty acids, and phosphates.[1]
- Biochem/physiol Actions: 18:2 Lysophosphatidic acid (LPA) is an active ingredient of gintonin, which is a bioactive ligand of ginseng. LPA is synthesized in plants by the activity of the enzyme glycerol 3-phosphate acyltransferase (GPAT). LPA is an intermediate in the synthesis of phosphatidic acid (PA) and other phospholipids.[1] Abnormal LPA metabolism is found in children with autism.[2]
- Packaging: 5 mL Clear Glass Sealed Ampule (857138C-10mg)
SAFETY INFORMATION
Pictograms
Signal Word
Danger
Hazard Statements
Precautionary Statements
P201 - P273 - P301 + P312 + P330 - P302 + P352 - P304 + P340 + P311 - P308 + P313
Hazard Classifications
Acute Tox. 3 Inhalation - Acute Tox. 4 Oral - Aquatic Chronic 3 - Carc. 2 - Eye Irrit. 2 - Repr. 2 - Skin Irrit. 2 - STOT RE 1 - STOT SE 3
Target Organs
Central nervous system, Liver,Kidney
WGK
WGK 3
Compare Similar Items
Show Difference
description: 1-linoleoyl-2-hydroxy-sn-glycero-3-phosphate (sodium salt), chloroform
Assay: >99% (LPA; may contain up to 10% of the 2-LPA isomer, TLC)
form: liquid
packaging: pkg of 1 × 1 mL (857138C-10mg)pkg of 1 × 2.5 mL (857138C-25mg)
manufacturer/tradename: Avanti Polar Lipids
concentration: 10 mg/mL (857138C-10mg)10 mg/mL (857138C-25mg)
lipid type: cardiolipinsphospholipids
shipped in: dry ice
storage temp.: −20°C
description: __
Assay: ≥99% (TLC)
form: chloroform solution
packaging: pkg of 1 × 1 mg (857144C-1MG)
manufacturer/tradename: Avanti Polar Lipids
concentration: __
lipid type: phospholipids
shipped in: dry ice
storage temp.: −20°C
description: __
Assay: __
form: liquid
packaging: __
manufacturer/tradename: __
concentration: 40-60% (GC)
lipid type: __
shipped in: __
storage temp.: __
